The Safety and Efficacy of Bipolar Plasma-Kinetic Transurethral Resection of The Prostate in Patients Taking Low-Dose Aspirin.

IF 1.5 4区医学 Q3 UROLOGY & NEPHROLOGY

Urology Journal Pub Date : 2023-12-26 DOI:10.22037/uj.v20i.7508

Jie Wu, Hongyan Li, Rongzhen Tao, Qinglai Tang

{"title":"The Safety and Efficacy of Bipolar Plasma-Kinetic Transurethral Resection of The Prostate in Patients Taking Low-Dose Aspirin.","authors":"Jie Wu, Hongyan Li, Rongzhen Tao, Qinglai Tang","doi":"10.22037/uj.v20i.7508","DOIUrl":null,"url":null,"abstract":"Purpose: To explore the safety and efficacy of bipolar plasma-kinetic transurethral resection of the prostate in patients taking low-dose aspirin.Materials and methods: Benign prostatic hyperplasia (BPH) patients who underwent surgical treatment from November 2018 to May 2020 were retrospectively analyzed, and divided into two groups according to whether taking 100mg aspirin daily aspirin or not. The perioperative indexes, complications and sequelae also were used to evaluate safety. The efficacy was evaluated by the functional outcomes in 3,6,12 months.Results: There were no statistical differences in the baseline characteristics or perioperative indicators and complications and sequelae, except for a longer operative time(90.49 ± 14.34 vs 84.95 ± 15.49; 95%CI: 0.26-10.83; P = .040) and a shorter hospital stay time(HST) (8.52 ± 1.55 vs 9.09 ± 1 .50; 95% CI: 0.21-1.11; P = .042) in the non-aspirin group. During the 12-months follow-up period, the functional outcomes of the two groups were significantly improved except International Index of Erectile Function (IIEF-5).Conclusion: Based on our research results, PKRP a safe and effective method for patients with BPH who taking 100mg aspirin daily.","PeriodicalId":23416,"journal":{"name":"Urology Journal","volume":" ","pages":"419-423"},"PeriodicalIF":1.5000,"publicationDate":"2023-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urology Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.22037/uj.v20i.7508","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: To explore the safety and efficacy of bipolar plasma-kinetic transurethral resection of the prostate in patients taking low-dose aspirin.

Materials and methods: Benign prostatic hyperplasia (BPH) patients who underwent surgical treatment from November 2018 to May 2020 were retrospectively analyzed, and divided into two groups according to whether taking 100mg aspirin daily aspirin or not. The perioperative indexes, complications and sequelae also were used to evaluate safety. The efficacy was evaluated by the functional outcomes in 3,6,12 months.

Results: There were no statistical differences in the baseline characteristics or perioperative indicators and complications and sequelae, except for a longer operative time(90.49 ± 14.34 vs 84.95 ± 15.49; 95%CI: 0.26-10.83; P = .040) and a shorter hospital stay time(HST) (8.52 ± 1.55 vs 9.09 ± 1 .50; 95% CI: 0.21-1.11; P = .042) in the non-aspirin group. During the 12-months follow-up period, the functional outcomes of the two groups were significantly improved except International Index of Erectile Function (IIEF-5).

Conclusion: Based on our research results, PKRP a safe and effective method for patients with BPH who taking 100mg aspirin daily.

查看原文本刊更多论文

服用低剂量阿司匹林的患者接受双极等离子动力经尿道前列腺切除术的安全性和有效性

目的：探讨服用小剂量阿司匹林的患者接受双极等离子动能经尿道前列腺切除术的安全性和有效性。材料与方法：对2018年11月至2020年5月接受手术治疗的良性前列腺增生（BPH）患者进行回顾性分析，按照是否每天服用100mg阿司匹林分为两组：回顾性分析2018年11月至2020年5月接受手术治疗的良性前列腺增生（BPH）患者，根据是否每日服用100mg阿司匹林分为两组。同时采用围手术期指标、并发症和后遗症来评价安全性。疗效通过 3、6、12 个月的功能结果进行评估：除了非阿司匹林组手术时间较长（90.49 ± 14.34 vs 84.95 ± 15.49; 95%CI: 0.26-10.83; P = .040）和住院时间较短（HST）（8.52 ± 1.55 vs 9.09 ± 1.50; 95%CI: 0.21-1.11; P = .042）外，其他基线特征、围术期指标、并发症和后遗症均无统计学差异。在12个月的随访期间，除国际勃起功能指数（IIEF-5）外，两组的功能结果均有明显改善：根据我们的研究结果，对于每天服用 100 毫克阿司匹林的良性前列腺增生症患者来说，PKRP 是一种安全有效的方法。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Urology Journal UROLOGY & NEPHROLOGY-

CiteScore

2.60

自引率

6.70%

发文量

审稿时长

6-12 weeks

期刊介绍： As the official journal of the Urology and Nephrology Research Center (UNRC) and the Iranian Urological Association (IUA), Urology Journal is a comprehensive digest of useful information on modern urology. Emphasis is on practical information that reflects the latest diagnostic and treatment techniques. Our objectives are to provide an exceptional source of current and clinically relevant research in the discipline of urology, to reflect the scientific work and progress of our colleagues, and to present the articles in a logical, timely, and concise format that meets the diverse needs of today’s urologist. Urology Journal publishes manuscripts on urology and kidney transplantation, all of which undergo extensive peer review by recognized authorities in the field prior to their acceptance for publication. Accordingly, original articles, case reports, and letters to editor are encouraged.